AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
16.88
+1.03 (6.50%)
Jan 21, 2025, 4:00 PM EST - Market closed
AnaptysBio Employees
AnaptysBio had 117 employees as of December 31, 2023. The number of employees increased by 21 or 21.88% compared to the previous year.
Employees
117
Change (1Y)
21
Growth (1Y)
21.88%
Revenue / Employee
$488,650
Profits / Employee
-$1,415,880
Market Cap
513.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ANAB News
- 14 days ago - Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data - Benzinga
- 5 weeks ago - AnaptysBio to abandon eczema drug development after mid-stage trial failure - Reuters
- 5 weeks ago - AnaptysBio abandons eczema drug development after mid-stage trial failure - Reuters
- 5 weeks ago - Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis - GlobeNewsWire
- 2 months ago - Anaptys Announces Participation in November and December Investor Conferences - GlobeNewsWire
- 2 months ago - Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Anaptys Announces Participation in September Investor Conferences - GlobeNewsWire